Filing Details

Accession Number:
0001209191-17-058940
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-11-02 17:33:12
Reporting Period:
2017-10-31
Accepted Time:
2017-11-02 17:33:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1373707 Tetraphase Pharmaceuticals Inc TTPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1598640 Jacques Dumas C/O Tetraphase Pharmaceuticals, Inc.
480 Arsenal Street
Watertown MA 02472
Chief Scientificofficer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-10-31 8,750 $3.69 8,750 No 4 M Direct
Common Stock Disposition 2017-10-31 8,750 $6.03 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2017-10-31 8,750 $0.00 8,750 $3.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
113,750 2027-01-29 No 4 M Direct
Footnotes
  1. The exercise and sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2017.
  2. Vests as to 6.25% of the shares on 4/30/2017 and further vests as to an additional 6.25% of the original grant at the end of each successive three-month period thereafter until 1/31/2021.